BCCI suspends India's rising star Prithvi Shaw for doping violation

In a statement released by Prithvi on his Twitter handle, he said he accepted his 'fate with all sincerity'.

Prthvi said he was 'shaken' by the news.

He said his experiences inspires other athletes in India and they should remain careful while consuming drug.

In its statement on Shaw, the BCCI said: "Mr. Prithvi Shaw registered with Mumbai Cricket Association, has been suspended for doping violation. Mr. Shaw had inadvertently ingested a prohibited substance, which can be commonly found in cough syrups."

"Mr. Shaw had provided a urine sample as part of the BCCI’s anti-doping testing program during the Syed Mushtaq Ali Trophy match on 22nd February 2019 in Indore. His sample was subsequently tested and found to contain Terbutaline. Terbutaline, a specified substance, is prohibited both In & Out of Competition in the WADA Prohibited List of Substances," the board said.

" On 16th July 2019, Mr. Shaw was charged with the commission of an Anti-Doping Rule Violation (ADRV) under the BCCI Anti-Doping Rules (ADR) Article 2.1 and provisionally suspended pending determination of the charge. Mr. Shaw responded to the charge by admitting the ADRV but asserting that it was inadvertent, being caused by his ingestion of the over the counter cough syrup he had taken for his cough," it said.

"The BCCI is satisfied with Mr. Shaw’s explanation that he had taken Terbutaline inadvertently to treat an Respiratory Tract Infection and not as a performance-enhancing drug. Having considered all of the evidence and taken expert external advice, the BCCI has accepted Mr. Shaw’s explanation of the cause of his ADRV, and on that basis has agreed that a period of ineligibility of eight months should apply, together with disqualification of certain results," read the statement.